ArticleRadiology case reports2025
Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: CT and MRI insights from a rare case.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress in the diagnosis and treatment of pseudomyxoma peritonei.World journal of surgical oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomyxoma peritonei (PMP) is a rare clinical condition, most commonly arising from appendiceal or ovarian mucinous neoplasms. This case report describes an exceptionally rare origin of PMP from a mucinous adenocarcinoma of the transverse colon, highlighting unique diagnostic and therapeutic challenges. Multimodality imaging played a crucial role in the diagnostic process, with computed tomography (CT) providing initial identification of low-attenuation peritoneal lesions with characteristic scalloping of visceral surfaces. Magnetic resonance imaging (MRI), less frequently reported in the literature for PMP, offered superior lesion characterization through high-resolution T2-weighted sequences, revealing hyperintense mucinous deposits. The combination of CT and MRI findings facilitated accurate diagnosis and staging, guiding surgical planning. Management involved cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), which remains the standard approach for PMP, improving survival in selected patients. This case underscores the critical role of comprehensive radiological assessment, particularly the added value of MRI, in enhancing diagnostic accuracy and optimizing patient outcomes in rare presentations of PMP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.